Categories AlphaGraphs, Earnings, Health Care
Highlights of Abbott Laboratories (ABT) Q4 2024 results
Abbott Laboratories (NYSE: ABT) on Wednesday announced financial results for the fourth quarter of 2024, reporting an increase in sales and adjusted profit.
Total reported sales increased 7.2% year-over-year to $10.9 billion in the December quarter. Organic sales for the underlying base business grew 10.1%.
Adjusted earnings moved up to $1.34 per share in Q4 from $1.19 per share in the year-ago quarter and matched Wall Street’s expectations. Unadjusted profit rose sharply to $9.23 billion or $5.27 per share in the fourth quarter from $1.60 billion or $0.91 per share in Q4 2023, reflecting a significant tax benefit.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Omnichannel push, margin dynamics in focus as Walmart gears up for Q3 earnings
Walmart Inc. (NYSE: WMT) entered the second half of FY26 navigating a challenging retail landscape marked by tariff-related cost pressure and cautious consumer behavior. At the same time, the company
AMAT Earnings: Applied Materials Q4 adjusted profit drops on lower revenues
Semiconductor equipment maker Applied Materials, Inc. (NASDAQ: AMAT) on Thursday reported a decrease in adjusted earnings for the fourth quarter of fiscal 2025. Adjusted earnings declined to $2.17 per share
Disney’s (DIS) streaming business continues its momentum in Q4 2025
Shares of The Walt Disney Company (NYSE: DIS) fell 9% on Thursday after the company delivered mixed results for the fourth quarter of 2025. While earnings beat expectations, revenues fell
